A. Benito-Vicente
Epidemiology · 2020–2022
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 36 citations into it
Whom A. Benito-Vicente trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from A. Benito-Vicente's perspective
Ordered by how strongly the researchers A. Benito-Vicente trusts endorse each paper. Same corpus, a different order for every researcher.
- Inflammation and metabolic disorders (Nature)
- History of Discovery: Inflammation in Atherosclerosis (Arteriosclerosis, Thrombosis and Vascular Biology)
- 10-year follow-up of intensive glucose control in type 2 diabetes. (New England Journal of Medicine)
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (Nature)
- Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (Nature)
- C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (Journal of the American Medical Association (JAMA))
- Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance (Science)
- Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance (Cell Metabolism)
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus (Diabetes)
- History of Discovery: The LDL Receptor (Arteriosclerosis, Thrombosis and Vascular Biology)
Their papers
- Pathophysiology of Atherosclerosis (2022) — 725 citations
- Pathophysiology of Type 2 Diabetes Mellitus (2020) — 2,131 citations